CVCA is currently participating in several research projects including: Evaluation of the use of NT pro-BNP levels in determining likelihood of cardiac disease and Determination of the clinical utility of biomarker cardiac Troponin I in dogs with pericardial effusion.
CVCA is currently participating in several research projects including: Evaluation of the use of NT pro-BNP levels in determining likelihood of cardiac disease and Determination of the clinical utility of biomarker cardiac Troponin I in dogs with pericardial effusion.